You are currently on the Switzerland version.
Looks like you are in United States.
Switch to local content?
The webinar focuses on testing the performance of AI tools, specifically a therapy planning tool (TPS) from deepeye Medical, in real-world clinical practice for treating neovascular age-related macular degeneration (nAMD). It compares the AI's performance to physician assessments and assessments under Reading-Center conditions.